SOX9 and cholestasis: The mouse line successfully avoided the potential lesions caused by embryonic-stage Sox9 deletion such as the delayed maturation of bile ducts, cholestasis, and the high levels of serum bilirubin [6, 47], and provided reference for studying the role of Sox9 in other organs.